2,343
Views
11
CrossRef citations to date
0
Altmetric
Mini-Review

Using biodosimetry to enhance the public health response to a nuclear incident

, , &
Pages S6-S9 | Received 24 Oct 2019, Accepted 19 May 2020, Published online: 21 Sep 2020

References

  • Abend M, Port M. 2018. Contribution of biodosimetry to different medical issues. Radiat Prot Dosimetry. 186(1):123–125.
  • Assistant Secretary for Preparedness and Response (ASPR). 2017. A decision makers guide: medical planning and response for a nuclear detonation. (HHS/ASPR), 2nd ed., November, 2017. [accessed 2020 Sep 14]. https://www.remm.nlm.gov/decisionmakersguide.htm.
  • Balajee AS, Bertucci A, Taveras M, Brenner DJ. 2014. Multicolour FISH analysis of ionising radiation induced micronucleus formation in human lymphocytes. Mutagenesis. 29(6):447–455.
  • Balog RP, Chang P, Javitz HS, Lee S, Lin H, Shaler T, Cooper DE. 2018. Development of a point-of-care radiation biodosimeter: studies using novel protein biomarker panels in non-human primates. Int J Radiat Biol. 96(1):1–12.
  • Bertucci A, Smilenov LB, Turner HC, Amundson SA, Brenner DJ. 2016. In vitro RABiT measurement of dose rate effects on radiation induction of micronuclei in human peripheral blood lymphocytes. Radiat Environ Biophys. 55(1):53–59.
  • Buddemeier B, Dillon M. 2009. Key response planning factors for the aftermath of nuclear terrorism LLNL-TR-410067 [accessed 2020 Sep 14]. https://www.remm.nlm.gov/IND_ResponsePlanning_LLNL-TR-410067.pdf.
  • Chen BJ, Deoliveira D, Spasojevic I, Sempowski GD, Jiang C, Owzar K, Wang X, Gesty-Palmer D, Cline JM, Bourland JD, et al. 2010. Growth hormone mitigates against lethal irradiation and enhances hematologic and immune recovery in mice and nonhuman primates. PLoS One. 5(6):e11056.
  • Coleman CN, Koerner JF. 2016. Biodosimetry: medicine, science, and systems to support the medical decision-maker following a large scale nuclear or radiation incident. Radiat Prot Dosimetry. 172(1–3):38–46.
  • Coleman CN, Weinstock DM, Casagrande R, Hick JL, Bader JL, Chang F, Nemhauser JB, Knebel AR. 2011. Triage and treatment tools for use in a scarce resources-crisis standards of care setting after a nuclear detonation. Disaster Med Public Health Prep. 5(S1):S111–S121.
  • Dainiak N. 2018. Medical management of acute radiation syndrome and associated infections in a high-casualty incident. J Radiat Res. 59(suppl_2):ii54–ii64.
  • Dainiak N, Gent RN, Carr Z, Schneider R, Bader J, Buglova E, Chao N, Coleman CN, Ganser A, Gorin C, et al. 2011. Literature review and global consensus on management of acute radiation syndrome affecting nonhematopoietic organ systems. Disaster Med Public Health Prep. 5(3):183–201.
  • Densow D, Kindler H, Baranov AE, Tibken B, Hofer EP, Fliedner TM. 1997. Criteria for the selection of radiation accident victims for stem cell transplantation. Stem Cells. 15(Suppl 2):287–297.
  • Farese AM, Cohen MV, Katz BP, Smith CP, Gibbs A, Cohen DM, MacVittie TJ. 2013. Filgrastim improves survival in lethally irradiated nonhuman primates. Radiat Res. 179(1):89–100.
  • FDA. 2016, 18 Apr. FDA Guidance: Radiation dosimetry Medical Countermeasure Devices.
  • Fenech M, Morley AA. 1986. Cytokinesis-block micronucleus method in human lymphocytes: effect of in vivo ageing and low dose X-irradiation. Mutat Res. 161(2):193–198.
  • Garty G, Amundson S, Laiakis E, Fornace A, Brenner D. 2017. Chapter XXXII, High throughput biodosimetry methods. Radiobiology and Methods Public Textbook. University of Pittsburgh, Pittsburgh, PA Centers for Medical Countermeasures against Radiation, National Institute of Allergy and Infectious Disease. p. 1–18.
  • Hankey KG, Farese AM, Blaauw EC, Gibbs AM, Smith CP, Katz BP, Tong Y, Prado KL, MacVittie TJ. 2015. Pegfilgrastim improves survival of lethally irradiated nonhuman primates. Radiat Res. 183(6):643–655.
  • Jacobs AR, Guyon T, Headley V, Nair M, Ricketts W, Gray G, Wong JYC, Chao N, Terbrueggen R. 2020. Role of a high throughput biodosimetry test in treatment prioritization after a nuclear incident. Int J Radiat Biol. 96(1):57–66.
  • Koenig KL, Goans RE, Hatchett RJ, Mettler FA, Schumacher TA, Noji EK, Jarrett DG. 2005. Medical treatment of radiological casualties: current concepts. Ann Emerg Med. 45(6):643–652.
  • Ostheim P, Haupt J, Herodin F, Valente M, Drouet M, Majewski M, Port M, Abend M. 2019. miRNA expression patterns differ by total- or partial-body radiation exposure in baboons. Radiat Res. 192(6):579–588.
  • Port M, Majewski M, Abend M. 2019. Radiation dose is of limited clinical usefulness in persons with Acute Radiation Syndrome. Radiat Prot Dosimetry. 186(1):126–129.
  • Sullivan JM, Prasanna PG, Grace MB, Wathen LK, Wallace RL, Koerner JF, Coleman CN. 2013. Assessment of biodosimetry methods for a mass-casualty radiological incident: medical response and management considerations. Health Phys. 105(6):540–554.
  • Valente M, Denis J, Grenier N, Arvers P, Foucher B, Desangles F, Martigne P, Chaussard H, Drouet M, Abend M, et al. 2015. Revisiting biomarkers of total-body and partial-body exposure in a baboon model of irradiation. PLoS One. 10(7):e0132194. eCollection.
  • Vral A, Fenech M, Thierens H. 2011. The micronucleus assay as a biological dosimeter of in vivo ionising radiation exposure. Mutagenesis. 26(1):11–17.
  • Waselenko JK, MacVittie TJ, Blakely WF, Pesik N, Wiley AL, Dickerson WE, Tsu H, Confer DL, Coleman CN, Seed T, et al. 2004. Medical management of the acute radiation syndrome: recommendations of the Strategic National Stockpile Radiation Working Group. Ann Intern Med. 140(12):1037–1051.